Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners - Wojtukiewicz, M Z; Rek, M M; Karpowicz, K (Cancer Metastasis Rev, 2021)